Chao Huang

Chao Huang

Auto-generated profile, based on publicly available information

Chao Huang

Pharmaceutical Development Ultragenyx Pharmaceutical Inc. Woburn Massachusetts USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2023 in Biotechnology Journal
Verified
Journal Article
Open access
WDWenjun Di
Wenjun Di
KKKyle Koczera
Kyle Koczera
PZPeilun Zhang
Peilun Zhang
DCDennis P. Chen
Dennis P. Chen
JWJames C. Warren
James C. Warren
CHChao Huang
Chao Huang
Recombinant adeno‐associated virus (rAAV) empty and full capsid separation has been a topic of interest in the rAAV gene therapy community for many years and the anion exchange chromatography (AEX) step has undergone various process optimizations to improve rAAV empty capsid separation, including AEX stationary phase, mobile phase, and process parameters. Here, we present a new AEX method that employs both weak partitioning chromatography (WPC) and multi‐column chromatography (MCC) to achieve improved full rAAV percentage in the AEX pool. The WPC technology allows empty rAAV to be displaced by full rAAV during loading, while the MCC technology enables parallel column processing which further increases AEX step productivity. Our results show that, compared to baseline AEX batch chromatography, the AEX‐WPC‐MCC method demonstrated improvements in both AEX pool full rAAV percentage (∼ 20% increase) and rAAV genome recovery (∼ 20% increase). As a result, the productivity (full capsid generated per liter of AEX column per hour of processing time) of the AEX step increased by ∼34‐fold from the baseline AEX batch run to the AEX‐WPC‐MCC run. It is foreseeable that this AEX‐WPC‐MCC method could find applications in large‐scale rAAV manufacturing processes to improve AEX yield and reduce the cost of goods of rAAV manufacturing.

5 December 2023 in Biotechnology Journal
Verified
Journal Article
Open access
DCDennis P. Chen
Dennis P. Chen
JWJulie Y. Wei
Julie Y. Wei
JWJames C. Warren
James C. Warren
CHChao Huang
Chao Huang
In the past decade, recombinant adeno‐associated virus (rAAV) has gained increased attention as a prominent gene therapy technology to treat monogenetic diseases. One of the challenges in rAAV production is the enrichment of full rAAV particles containing the gene of interest (GOI) payload. By adjusting the mobile phase properties of anion‐exchange chromatography (AEX), it was demonstrated that empty and full separation of rAAV was improved in monolith based preparative AEX chromatography. When compared to the baseline method using NaCl, the use of tetraethylammonium acetate (TEA‐Ac) in the AEX mobile phase resulted in enhanced resolution from 0.75 to 1.23 between “Empty” and “Full” peaks by salt linear gradient elution, as well as increased the percentage of full rAAV particles from 20% to 36% and genome recovery from 59% to 62%. Furthermore, a dual wash plus step elution AEX method was developed. Wherein, the first wash step harnesses TEA‐Ac to separate empty and full capsids, which is followed by a second wash step that ensures no TEA‐Ac salt is carried over into AEX eluate. The resulting optimized AEX purification method has the potential to be adapted for manufacturing and purification processes involving various rAAV production platforms that experience empty and full rAAV separation challenges.

9 February 2023
Verified
Preprint
Open access
PDF file
DCDennis Chen
Dennis Chen
JWJames Warren
James Warren
CHChao Huang
Chao Huang
In the past decade, recombinant adeno-associated virus (rAAV) has gained increased attention as a prominent gene therapy technology to treat monogenetic disease. One of the challenges in rAAV production is the enrichment of full-rAAV particles containing the gene of interested (GOI) payload. Herein, we demonstrated that by adjusting the mobile phase properties of anion-exchange chromatography (AEX), Empty and Full separation of rAAV was improved in monolith based preparative AEX chromatography. When compared to the baseline method using NaCl, the presence of tetraethylammonium acetate (TEA-Ac) in the AEX mobile phase resulted in enhanced resolution (from 0.75 to 1.23) between Empty and Full peaks by salt linear gradient elution, as well as increased the percentage of full-rAAV particles from 20% to 36% and GOI genome recovery (from 59% to 62%). Furthermore, a dual wash + step elution AEX method was developed to harness TEA-Ac contribution on Empty and Full separation in the first wash (wash1) step while removing TEA-Ac in the second wash (wash2) step to ensure product safety. The resulting optimized AEX purification method could be easily adapted in scaled-up manufacturing and could also be applied to purification processes involving other AAV serotypes facing similar Empty and Full rAAV separation challenges.